Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen

Hiroshi Kishikawa, Kayoko Hukuhara, Asako Ito, Kyoko Arahata, Sakiko Takarabe, Shogo Kaida, Jun Miyauchi, Soichiro Miura, Jiro Nishida

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

RESULTS: Ten gastric neoplasia cases (gastric cancer and adenoma) were found to be included. Multiple logistic regression analyses identified H. pylori antibody titer ≥3 U/ml (odds ratio=14.4, 95% confidence interval=2.7-76.9; p<0.01) and pepsinogen-I/II ratio ≤4.3 ng/ml (odds ratio=10.0, 95% confidence interval=2.1-47.9; p<0.01), but not age as independent predictive factors of neoplasia.

CONCLUSION: Endoscopy should be considered in individuals with H. pylori antibody titer of ≥3 U/ml and a pepsinogen-I/II ratio of ≤4.3 in those classed as group A by ABC method.

BACKGROUND/AIM: Individuals negative for Helicbacter pylori antibody and with a normal pepsinogen test (group A) are regarded as being at low risk in serum gastric cancer screening known as the ABC method, and endoscopy is not recommended; however, this group may include 2-10% of gastric cancer cases.

PATIENTS AND METHODS: A total of 345 individuals who underwent upper gastrointestinal endoscopy and were classified by ABC as group A (H. pylori antibody titer <10 U/ml, and pepsinogen-I >70 ng/ml or I/II ratio >3) were enrolled, and predictors of gastric neoplasia were investigated.

Original languageEnglish
Pages (from-to)6765-6771
Number of pages7
JournalAnticancer Research
Volume35
Issue number12
Publication statusPublished - 2015 Dec 1
Externally publishedYes

Fingerprint

Pepsinogen A
Helicobacter pylori
Stomach
Antibodies
Adenoma
Stomach Neoplasms
Neoplasms
Logistic Models
Odds Ratio
Regression Analysis
Confidence Intervals

Keywords

  • ABC method
  • Gastric cancer
  • Helicobacter pylori
  • pepsinogen
  • screening

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Kishikawa, H., Hukuhara, K., Ito, A., Arahata, K., Takarabe, S., Kaida, S., ... Nishida, J. (2015). Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen. Anticancer Research, 35(12), 6765-6771.

Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen. / Kishikawa, Hiroshi; Hukuhara, Kayoko; Ito, Asako; Arahata, Kyoko; Takarabe, Sakiko; Kaida, Shogo; Miyauchi, Jun; Miura, Soichiro; Nishida, Jiro.

In: Anticancer Research, Vol. 35, No. 12, 01.12.2015, p. 6765-6771.

Research output: Contribution to journalArticle

Kishikawa, H, Hukuhara, K, Ito, A, Arahata, K, Takarabe, S, Kaida, S, Miyauchi, J, Miura, S & Nishida, J 2015, 'Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen', Anticancer Research, vol. 35, no. 12, pp. 6765-6771.
Kishikawa, Hiroshi ; Hukuhara, Kayoko ; Ito, Asako ; Arahata, Kyoko ; Takarabe, Sakiko ; Kaida, Shogo ; Miyauchi, Jun ; Miura, Soichiro ; Nishida, Jiro. / Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen. In: Anticancer Research. 2015 ; Vol. 35, No. 12. pp. 6765-6771.
@article{c184c7ff63ca4722b1bdc7602bf3b479,
title = "Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen",
abstract = "RESULTS: Ten gastric neoplasia cases (gastric cancer and adenoma) were found to be included. Multiple logistic regression analyses identified H. pylori antibody titer ≥3 U/ml (odds ratio=14.4, 95{\%} confidence interval=2.7-76.9; p<0.01) and pepsinogen-I/II ratio ≤4.3 ng/ml (odds ratio=10.0, 95{\%} confidence interval=2.1-47.9; p<0.01), but not age as independent predictive factors of neoplasia.CONCLUSION: Endoscopy should be considered in individuals with H. pylori antibody titer of ≥3 U/ml and a pepsinogen-I/II ratio of ≤4.3 in those classed as group A by ABC method.BACKGROUND/AIM: Individuals negative for Helicbacter pylori antibody and with a normal pepsinogen test (group A) are regarded as being at low risk in serum gastric cancer screening known as the ABC method, and endoscopy is not recommended; however, this group may include 2-10{\%} of gastric cancer cases.PATIENTS AND METHODS: A total of 345 individuals who underwent upper gastrointestinal endoscopy and were classified by ABC as group A (H. pylori antibody titer <10 U/ml, and pepsinogen-I >70 ng/ml or I/II ratio >3) were enrolled, and predictors of gastric neoplasia were investigated.",
keywords = "ABC method, Gastric cancer, Helicobacter pylori, pepsinogen, screening",
author = "Hiroshi Kishikawa and Kayoko Hukuhara and Asako Ito and Kyoko Arahata and Sakiko Takarabe and Shogo Kaida and Jun Miyauchi and Soichiro Miura and Jiro Nishida",
year = "2015",
month = "12",
day = "1",
language = "English",
volume = "35",
pages = "6765--6771",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "12",

}

TY - JOUR

T1 - Predictors of Gastric Neoplasia in Cases Negative for Helicobacter pylori Antibody and with Normal Pepsinogen

AU - Kishikawa, Hiroshi

AU - Hukuhara, Kayoko

AU - Ito, Asako

AU - Arahata, Kyoko

AU - Takarabe, Sakiko

AU - Kaida, Shogo

AU - Miyauchi, Jun

AU - Miura, Soichiro

AU - Nishida, Jiro

PY - 2015/12/1

Y1 - 2015/12/1

N2 - RESULTS: Ten gastric neoplasia cases (gastric cancer and adenoma) were found to be included. Multiple logistic regression analyses identified H. pylori antibody titer ≥3 U/ml (odds ratio=14.4, 95% confidence interval=2.7-76.9; p<0.01) and pepsinogen-I/II ratio ≤4.3 ng/ml (odds ratio=10.0, 95% confidence interval=2.1-47.9; p<0.01), but not age as independent predictive factors of neoplasia.CONCLUSION: Endoscopy should be considered in individuals with H. pylori antibody titer of ≥3 U/ml and a pepsinogen-I/II ratio of ≤4.3 in those classed as group A by ABC method.BACKGROUND/AIM: Individuals negative for Helicbacter pylori antibody and with a normal pepsinogen test (group A) are regarded as being at low risk in serum gastric cancer screening known as the ABC method, and endoscopy is not recommended; however, this group may include 2-10% of gastric cancer cases.PATIENTS AND METHODS: A total of 345 individuals who underwent upper gastrointestinal endoscopy and were classified by ABC as group A (H. pylori antibody titer <10 U/ml, and pepsinogen-I >70 ng/ml or I/II ratio >3) were enrolled, and predictors of gastric neoplasia were investigated.

AB - RESULTS: Ten gastric neoplasia cases (gastric cancer and adenoma) were found to be included. Multiple logistic regression analyses identified H. pylori antibody titer ≥3 U/ml (odds ratio=14.4, 95% confidence interval=2.7-76.9; p<0.01) and pepsinogen-I/II ratio ≤4.3 ng/ml (odds ratio=10.0, 95% confidence interval=2.1-47.9; p<0.01), but not age as independent predictive factors of neoplasia.CONCLUSION: Endoscopy should be considered in individuals with H. pylori antibody titer of ≥3 U/ml and a pepsinogen-I/II ratio of ≤4.3 in those classed as group A by ABC method.BACKGROUND/AIM: Individuals negative for Helicbacter pylori antibody and with a normal pepsinogen test (group A) are regarded as being at low risk in serum gastric cancer screening known as the ABC method, and endoscopy is not recommended; however, this group may include 2-10% of gastric cancer cases.PATIENTS AND METHODS: A total of 345 individuals who underwent upper gastrointestinal endoscopy and were classified by ABC as group A (H. pylori antibody titer <10 U/ml, and pepsinogen-I >70 ng/ml or I/II ratio >3) were enrolled, and predictors of gastric neoplasia were investigated.

KW - ABC method

KW - Gastric cancer

KW - Helicobacter pylori

KW - pepsinogen

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=84973408071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973408071&partnerID=8YFLogxK

M3 - Article

C2 - 26637894

AN - SCOPUS:84973408071

VL - 35

SP - 6765

EP - 6771

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 12

ER -